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Abstract 
Objective: Osteoporosis is known to impair the process of implant osseointegration.  
The recent discovery that statins (HMG-CoA reductase inhibitors) act as bone 
anabolic agents, suggests statins can be used as potential agents in the treatment of 
osteoporosis. Therefore, we hypothesized that statins will promote osteogenesis 
around titanium implants in subjects with osteoporosis. 
Materials and methods: Fifty-four female Sprague Dawley rats, aged 3 months old, 
were randomly divided into three groups: Sham-operated group (SHAM; n=18); 
ovariectomized group (OVX; n=18); and ovariectomized with Simvastatin treatment 
group (OVX+SIM; n=18). 56 days after being ovariectomized (OVX), screw-shaped 
titanium implants were inserted into the tibiae.  Simvastatin was administered orally 
at 5mg/kg each day after the placement of the implant in the OVX+SIM group. The 
animals were sacrificed at either 28 or 84 days after implantation and the 
undecalcified tissue sections were obtained.  Bone-to-implant contact (BIC) and 
bone area (BA) within the limits of implant threads were measured around the cortical 
(zone A) and cancellous (zone B) bone regions. Furthermore, bone density (BD) of 
zone B in a 500 µm -wide zone lateral to the implants was also measured. 
Results: There were no significant differences in BIC and BA measurements in zone 
A in any of the three groups at either 28 or 84 days after implantation (P>0.05). By 
contrast, in zone B significant differences in the measurement of BIC, BA, and BD 
were observed at 28 and 84 days between all three groups. Bone healing decreased 
with lower BIC, BA and BD around implant in OVX group compared with other two 
groups and Simvastatin reversed the negative effect of OVX on bone healing around 
implants with the improvement of BIC, BA, and BD in zone B. 
Conclusion: Osteoporosis can significantly influence bone healing in the cancellous 
bone around titanium implants and Simvastatin was shown to significantly improve 
the osseointegration of pure titanium implants in osteoporotic rats. 
INTRODUCTION 
The successful outcome of dental implants depends on the firm osseointegration of 
implants which depends on there being sufficient bone tissue in the jawbone. There 
are various factors that may adversely affect the osseointegration of implants such as 
implant material, shape, and surface chemistry and patient variables such as bone 
quantity and quality (Puleo & Nanci 1999).  Osteoporosis has been defined as a 
systemic skeletal disease characterized by gradual loss and microarchitectural 
deterioration of bone tissue which results in increased bone fragility and susceptibility 
to fracture (Wactawski-Wende 2001). Previous researchers have demonstrated that 
osteoporosis can impair the process of implant osseointegration ( Motohashi, et al. 1999, 
Yamazaki, et al. 1999, Pan, et al. 2000, Lugero, et al. 2000, Duarte, et al. 2003, Duarte, et al. 
2005) . Osteoporosis must therefore be considered one of the most important factors in 
the failure of implant osseointegration. 
Various therapeutic approaches, seeking to improve osseointegration of implants with 
bone affected by osteoporosis, have been reported (Qi, et al. 2004). However, most 
drugs currently available for treatment of osteoporosis predominantly work by 
suppressing bone resorption, which slows down bone turnover resulting in reduced 
bone loss. In order to improve osseointegration of implants in osteoporotic bone, 
drugs capable of enhancing bone formation are therefore more relevant from a clinical 
perspective. The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase 
inhibitor, Simvastatin, is a widely used cholesterol-lowering drug and inhibits hepatic 
cholesterol biosynthesis. Recent studies have shown the beneficial effects of statins on 
bone mineral density (Uzzan, et al. 2007, Serin-Kilicoglu & Erdemli, 2007). It has 
been suggested that several statin drugs, including Simvastatin, increase the mRNA 
expression of BMP-2 in osteoblasts, with a subsequent increase in bone formation, 
when injected subcutaneously over the murine calvaria (Mundy, et al. 1999).  Several 
animal and human studies have been performed to elucidate the clinical importance of 
statins. Most experimental and epidemiological studies have shown statins to have 
beneficial effects on bone metabolism, as evaluated by bone mineral density (BMD) 
(Bauer, et al. 2004, Montagnani, et al. 2003, Rejnmark, et al. 2004) and fracture risk (Pasco, et 
al. 2002, van Staa,et al 2001, Skoglund, et al. 2002). Statins have therefore been proposed as 
potential agents in the treatment of osteoporosis. Previous studies also suggest that 
Simvastatin can promote osteogenesis around titanium implants (Ayukawa, et al. 2004). 
To our knowledge there are no studies that have investigated the effects of statins on 
bone healing around titanium implants in subjects with osteoporosis. In this study we 
evaluate, by histometric analysis, whether Simvastatin can promote bone healing 
around titanium implants in an osteoporosis rat model. 
 
MATERIALS AND METHODS 
Experimental Animals 
Fifty-four 3 months old female Sprague-Dawley rats, weighing approximately 
240-300g at the beginning of the experiments, were obtained from the animal 
resource centre (SLAC laboratory animal Co. Ltd, Shanghai, China). The rats were 
housed at the university animal house with controlled room temperature (22±2 0C) 
and humidity (50±20%). The room light was controlled with a 12hr light - 12hr dark 
cycle. Commercial laboratory rat chow (Experimental Animal Centre of Zhejiang 
University, China) and water were available ad libitum. The study was conducted 
according to a protocol approved by the Animal Care and Use Committee of Fujian 
Medical University.   
Experimental design 
The rats were anesthetized by abdominal administration of 2.5% pentobarbital 
sodium (Chemical Agent Co, Shanghai, China) at 45mg/kg body weight. The animals 
were divided into three groups and each group contained 18 rats by randomized block 
design: Sham-operated group (SHAM) (n=18); ovariectomized group (OVX) (n=18); 
and ovariectomized with Simvastatin treatment group (OVX+SIM) (n=18). In the 
OVX and OVX+SIM groups the ovaries were exposed and completely excised 
bilaterally, using an abdominal approach (Geary & Asarian 2001). In the SHAM group 
the ovaries were exposed and equal volumes of fat tissue besides each ovary was 
excised. After surgery the fascia and skin were closed and sutured. Nine animals from 
each group were sacrificed either at 28 or 84 days after implantation. 
Implantation and treatment  
Screw-shaped implants made from commercially pure titanium were used in this 
study (Jiuzhou Co, Xian, China). Total length of each implant was 5mm, thread 
diameter was 2mm, and pitch 1mm. The implants were cleaned in absolute ethanol in 
an ultrasonic bath and sterilized by autoclaving. Osteoporotic changes due to 
ovariectomy was verified by sacrificing two rats from each group and recovering the 
proximal tibial metaphyses and uterine horns 56 days after the operation. The 
specimens were fixed in 10% neutral buffered formalin. The tibiae were decalcified 
with 5% nitric acid, trimmed and embedded in paraffin. Cross sections of uterine horn 
were cut and 5μm thick sections longitudinal to the axis of tibiae were prepared and 
stained with haematoxylin-eosin (H&E) for light microscope examination.  
56 days after ovariectomy surgery, screw shaped titanium implants were inserted 
in the left tibiae of each rat according to a method described in a previous study 
(Nociti et al. 2002). Briefly, under general anaesthesia, the surface of proximal 
metaphases of the tibiae was exposed by an incision approximately 10 mm in length.  
Under constant saline irrigation, bicortical implant beds were drilled with a dental 
burr (Zhongbang, Co, Xian, China) at a rotary speed not exceeding 1500 rpm and the 
implant was placed until the screw thread had been completely introduced into the 
bone cortex, after which the soft tissue was replaced and sutured. Simvastatin was 
administered orally at 5mg /kg per day according to the previous study (Mundy, et al. 
1999) after implant surgery to the OVX+SIM group.  Saline was given as a placebo 
to the other two groups. 
Histometric procedure 
After sacrificing the rats the left tibiae with the pure titanium implant were 
harvested and fixed in 4% neutral formalin for 48 hours. The specimens were 
dehydrated in a series of graded alcohol and embedded in polyester resin without 
decalcification. Undecalcified sections, approximately 50μm thick and longitudinal to 
the implant, were cut with Letize 1600 saw microtome and bone grinding slice 
technique. Three sections were obtained from each tibia and stained with 0.1% 
toluidine blue and methylene blue-basic fuchsin solution separately for light 
microscopy. The percentage of bone-to-implant contact (BIC%) and bone area (BA%) 
from both sides of the implant in the cortical (zone A) and cancellous (zone B) areas, 
and bone density (BD%) in a 500 µm -wide zone lateral to the implants surface in 
zone B were measured bilaterally according previous methods (Duarte, et al. 2003, Nociti, 
et al. 2002). The data from three sections per specimen were averaged. 
Statistical methods 
The data of all rats were summarized, presenting mean ± standard deviation (SD). 
Statistical analyses were performed using the SigmaStatTM statistics package (SPSS 
Inc., USA). A Wilk-Shapiro test for normality was conducted on all parameters and a 
one-way analysis of variance (ANOVA) was carried out on all groups followed by 
post hoc Turkey’s test (alpha=0.05) to determine the difference between individual 
groups. In the Zone B group of BA (unequal variances (p=0.022) in parameters), the 
Kruskal-Wallis test (KW-test) was performed. If KW-test was significant, the 
Nemenyi’s nonparametric multiple comparison was performed. Additionally, the 
multivariate analysis of variance (MANOVA) test was used to compare the effects of 
bone healing based on the parameters of BIC, BA, and BD between 28 days and 84 
days of each relevant group. 
 
RESULTS 
Bone and uterine horns histological changes after ovariectomy 
At day 56 after ovariectomy proximal tibial metaphyses showed significant 
osteoporotic changes in both the OVX and OVX+SIM groups. In the area of cancellous 
bone, the trabeculae were sparse, irregular and discontinuous. Significant atrophy was 
seen in the uterine horn after ovariectomy. The cavities were small and the glandular 
organs were scarce. By contrast, in the SHAM group the trabeculae were dense and 
arranged regularly in the tibia. The glandular organs of uterine horn were abundant with 
the normal size of uterine horn cavity (Fig. 1).  
Light microscopy 
Twenty-eight days after implantation, both SHAM and OVX+ SIM groups 
showed similar morphologies. The preexisting cancellous bone areas were connected 
and newly formed bone was seen around the implant surface forming a reticular 
structure. In the area of cortical bone most of the implant surface was in direct contact 
with the new woven bone. In the area of the medullary cavity most of the implant 
surface was covered with a thick new bone lamella, which was connected with 
preexisting bone by newly formed trabeculae at several locations. In some areas of the 
interface, between implants and new bone, a layer of early fibrous woven bone could 
be detected. Osteocytes were apparent in the newly formed bone matrix surrounding 
the implant. In the OVX groups preexisting cancellous bone around the implants was 
thin and sparse compared with the OVX+SIM and SHAM groups. The new bone 
covering the implant surface was thin and disconnected (Fig. 2). 
 
84 days after implantation histological results showed more newly formed trabeculae 
than at 28 days in both the SHAM and OVX+ SIM groups. The changes in both 
groups were similar in the cancellous and cortical bone areas. The newly formed bone 
attached to the implant surface had matured and become thicker compared to those at 
28 days. At 84 days the amount of new bone on implant surface in all three groups 
was more than the new bone formation at 28 days respectively. In the OVX group the 
amount of new bone covering the implant surface was thin and disconnected 
compared to the new bone formation seen in the OVX+SIM and SHAM groups. 
However, in the cortical bone area, most of the implant surfaces were covered with 
mature lamella bone, and no significant differences were seen between the three 
groups (Fig. 3).    
Histomorphometry 
Intergroup comparisons showed that Simvastatin promoted bone healing around 
implants in cancellous bone, but had no effect on the bone healing around implants in 
the cortical bone area. In zone A (cortical bone area) intergroup analysis did not reveal 
any significant difference among the three groups in the measurement of BIC and BA 
(ANOVA test, P>0.05) at either 28 or 84 days after implantation. In zone B 
(cancellous bone area) the measurement of BIC, BA, and BD showed significantly 
difference among the three groups (for 28 days, P=0.012 (BIC), P=0.005 (BA, 
Kruskal-Wallis test), P=0.003 (BD) and for 84 days, P=0.005 (BIC)，P=0.001(BA), 
P=0.002 (BD)). The BIC, BA, and BD showed higher volume in the SHAM and 
OVX+SIM groups than the OVX group (for 28 days, OVX+SIM VS OVX, P=0.012 
(BIC), P=0.044 (BA, Nemenyi’s test ), P=0.018 (BD); SHAM vs OVX, P=0.007 
(BIC), P=0.009 (BA, Nemenyi’s test ), P=0.001 (BD)and for 84 days, OVX+SIM VS 
OVX,  P=0.023 (BIC), P=0.001 (BA), P=0.029(BD); SHAM vs OVX, P=0.002 
(BIC), P=0.001 (BA), P=0.001 (BD)). All three groups showed better bone healing 
around implants in 84 days compared with 28 days (MANOVA test, alpha=0.05, 
F=56.806, P<0.001). However, no difference was observed between SHAM and 
OVX+SIM groups at either 28 or 84 days after implantation (Turkey’s test, P>0.05). 
(Tables 1 and 2). 
 
DISCUSSION 
The 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitor, 
Simvastatin, is a widely used cholesterol-lowering drug, which inhibits cholesterol 
biosynthesis. Statins lower cholesterol synthesis by the inhibition of the mevalonate 
pathway. Recently, it has been reported that the liposoluble statin, Simvastatin, could 
increase the expression of bone morphogenetic protein (BMP)-2 mRNA in osteoblasts 
and, as a result, promote bone formation (Mundy, et al. 1999). The anabolic effect of 
statins on bone metabolism have further been reported in a number of animal studies 
(Skoglund, et al. 2002, Oxlund, et al. 2001, Pytlik, et al. 2003). This phenomenon has 
generated great interest amongst researchers to investigate potential applications of 
statins in the treatment of some bone related diseases, as well as implantology.  
Despite this level of interest, there are no reports, to our knowledge, that evaluate the 
potential role of statins on the bone quality around titanium implants placed in 
osteoporotic subjects, although a limited number of studies have reported the effects 
of statins on the osseointegration of implants (Ayukawa, et al. 2004).   
In this study, we investigated the potential application of Simvastatin to improve 
osseointegration of titanium implants in rats with ovariectomy induced osteoporosis.  
This osteoporosis model has frequently been used to study postmenopausal 
osteoporosis patients undergoing oral implantation in a clinical setting (Motohashi, et al. 
1999, Pan, et al. 2000, Duarte, et al. 2003, Duarte, et al. 2005, Qi, et al. 2004). 
56 days after having undergone ovariectomy, the histological changes of proximal 
tibial metaphysis and uterine horns confirmed that the ovaries in the rats of OVX and 
OVX+SIM groups had been completely excised and osteoporosis successfully 
induced.  
It is widely accepted that bone quality is an important factor governing the success 
of titanium implants. The negative effects of osteoporosis on implant osseointegration 
have been reported in several preclinical studies conducted in OVX animals 
(Motohashi, et al. 1999, Yamazaki, et al. 1999, Pan, et al. 2000, Lugero, et al. 2000, Duarte, et al. 
2003, Duarte, et al. 2005). In our study, both 28 and 84 days after implantation, the BIC 
and BD in zone A and zone B, and BA in zone B were significantly decreased in OVX 
group compared with SHAM group (Tables 1 and 2). Similar observations in previous 
studies also showed decreased BIC, BD, and BA in osteoporotic rats (Duarte, et al. 
2003). These results suggests that osseointegration of implants may be compromised 
in patients with primary osteopenia, osteoporosis, or secondary osteoporosis (for 
example, due to rheumatoid arthritis and/or prolonged corticosteroid treatment). 
In our study we demonstrated that the administration of 5mg/kg/day of Simvastatin 
induce a significant increase in BIC, BD, and BA in zone B at 28 and 84 days in OVX 
rats. Moreover, we observed no difference between the OVX+SIM groups and SHAM 
groups (Tables 1 and 2). These results suggest that Simvastatin can effectively 
overcome the negative impact osteoporosis exert on the osseointegration of titanium 
implants.  Simvastatin appears to promote bone healing around titanium implants by 
increasing implant-bone contact rate and cancellous bone volume, thus obtaining 
secondary stability.  
The enhanced bone formation around implant, induced by Simvastatin in 
osteoporotic rats, may be associated with an increased expression of the bone 
morphogenic protein 2, which stimulates osteoblast differentiation (Mundy, et al. 1999).  
Statin drugs are known to enhance the expression of VEGF, a bone anabolic factor, in 
osteoblasts (Maeda, et al. 2003) and to regulate osteoblast function by increasing the 
expression of bone sialoprotein (BSP), osteocalcin (OCN), and type I collagen 
(COL1), as well as suppressing the gene expression of collagenases such as MMP-1 
and MMP-13 (Maeda, et al. 2004). In addition, by competitive inhibition of HMG-CoA 
reductase, statins interfere with the malevonate pathway, leading to decreased protein 
prenylation, necessary for normal osteoclast function (Mundy, et al. 1999). The action of 
the former would have an anabolic effect on bone and the latter would have an 
antiresorptive effect, similar to the biphosphonates that act downstream in the 
malevonate pathway.  
In summary, the present study has observed, histologically, that Simvastatin 
influences bone healing around titanium implants in osteoporotic rats, which supports 
the anabolic effect of Simvastatin on bone metabolism in OVX rats. The results 
suggest a potential application of Simvastatin in dental implantation for osteoporosis 
patient. However, more studies are needed, by investigating whether Simvastatin 
plays a similar role in humans. 
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Legends: 
Figure 1. Comparison of the changes of uterus and proximal tibia in SHAM (A and C) 
and OVX (B and D) groups at 56 days after surgery.  The size of uterus and the 
uterus cavity were normal at SHAM rats with abundant glandular organ in 
comparison to the OVX rat, which showed significantly decrease in the size of uterus 
and uterus cavity (H&E stain with 4x magnification).  The regularity and connectivity 
of trabecular were disrupted at the OVX rats (D) compared to the SHAM rats (C) 
(Hematoxylin and Eosin stain with 4x magnification). Bar = 2mm.   
 
Figure 2. Histological observations after 28 days of implantation in proximal tibia.  
The new bone formation on implant surface in SHAM (A and D) and OVX+SIM (C 
and F) groups showed similar changes.  Most of the implant surface was in direct 
contact with the new woven bone and newly formed trabeculae around implants were 
connected with preexisting bone.  The new bone formation around implant surface in 
OVX group (B and E) was thin and discontinuous. (A, B, and C magnification 2x, bar 
= 2mm; D, E, and F magnification 10x, bar = 0.5mm).  
 
Figure 3. Histological observations after 84 days of implantation in proximal tibia. 
The new bone around implant surface in SHAM (A and D) and OVX+SIM (C and F) 
groups was significantly thicker than the new bone formed on implant surface in 
OVX group (B and E).  The amount of new bone on implant surface after 84 days in 
all three groups was more than the new bone at 28 days respectively. (A, B, and C 
magnification 2x, bar=2mm; D, E, and F magnification 10x, bar=0.5mm). 
                                                                                     
Table 1  Bone histomorphometric indices at 28 days after implantation（ x ±SD，%） 
BIC BA BD Groups 
Zone A Zone B∆ Zone A Zone B∆ Zone B∆ 
SHAM 70.48±6.86 58.00±11.95 60.09±18.71 31.81±11.82 25.10±9.19 
OVX 72.94±4.92 34.92±12.63*# 68.52±17.99 14.45±4.44*# 9.81±4.18*# 
OVX + SIM 72.50±6.69 56.06±17.31 72.41±12.45 27.03±8.06 19.63±7.01 
∆: P=0.012 (BIC), 0.005 (BA, Kruskal-wallis test), 0.003 (BD)  
*: P=0.007 (BIC), 0.009 (BA, Nemenyi’ test), 0.001 (BD) vs: SHAM group  
#: P=0.012 (BIC), 0.044 (BA, Nemenyi’ test), 0.018 (BD) vs: OVX+SIM group. 
Data are means ± SD. 
 
 Table 2  Bone histomorphometric indices at 84 days after implantation（ x ±SD，%） 
Groups BIC BA BD 
 Zone A Zone B∆ Zone A Zone B∆ Zone B∆ 
SHAM 86.88±5.60 79.47±12.06 84.72±4.74 51.61±9.42 31.74±10.29 
OVX 79.48±6.26 55.84±15.20*# 85.56±6.66 25.03±7.56*# 15.72±5.05*# 
OVX + SIM 83.38±6.49 71.78±7.26 83.38±5.98 41.66±6.54 24.67±4.32 
∆: P=0.005 (BIC), 0.001 (BA), 0.002 (BD) 
*: P=0.002 (BIC), 0.001 (BA), 0.029 (BD) vs: SHAM group   
#: P=0.001 (BIC), P=0.001 (BA), P=0.029 (BD) vs: OVX+SIM group.  
Data are means ± SD. 
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